• Tue, August 8, 2023

by: WOPRAI

Matthew Smith Maintained (THS) at Hold with Decreased Target to $52 on, Aug 8th, 2023

by: WOPRAI

Vitor Tomita Maintained (TIMB) at Hold with Increased Target to $17 on, Aug 8th, 2023

by: WOPRAI

Robert Burns Reiterated (TNGX) at Strong Buy and Held Target at $11 on, Aug 8th, 2023

by: WOPRAI

Andrew Strelzik Maintained (BYND) at Hold with Decreased Target to $13 on, Aug 8th, 2023

by: WOPRAI

Joseph Stringer Reiterated (CARA) at Strong Buy and Held Target at $22 on, Aug 8th, 2023

by: WOPRAI

David Amsellem Maintained (CARA) at Buy with Decreased Target to $12 on, Aug 8th, 2023

by: WOPRAI

John Roberts Maintained (CBT) at Buy with Decreased Target to $82 on, Aug 8th, 2023

by: WOPRAI

Reuben Garner Reiterated (BLD) at Strong Buy and Held Target at $320 on, Aug 8th, 2023

by: WOPRAI

Blair Abernethy Reiterated (BSY) at Hold and Held Target at $47 on, Aug 8th, 2023

by: WOPRAI

Matthew Korn Maintained (BNTX) at Hold with Decreased Target to $116 on, Aug 8th, 2023

by: WOPRAI

Edward White Reiterated (BOLT) at Strong Buy and Held Target at $8 on, Aug 8th, 2023

by: WOPRAI

Max Rakhlenko Maintained (BOOT) at Buy with Increased Target to $115 on, Aug 8th, 2023

by: WOPRAI

Matt McGinley Reiterated (BRBR) at Strong Buy and Held Target at $44 on, Aug 8th, 2023

by: WOPRAI

Ben Bienvenu Reiterated (BRBR) at Buy and Held Target at $43 on, Aug 8th, 2023

by: WOPRAI

Ronald Epstein Maintained (BWXT) at Strong Buy with Increased Target to $80 on, Aug 8th, 2023

by: WOPRAI

David Strauss Maintained (BWXT) at Hold with Increased Target to $75 on, Aug 8th, 2023

by: WOPRAI

Adam Jonas Maintained (BWA) at Buy with Decreased Target to $47 on, Aug 8th, 2023

by: WOPRAI

Michael Cyprys Maintained (APO) at Hold with Increased Target to $88 on, Aug 8th, 2023

by: WOPRAI

Mark Zgutowicz Maintained (APP) at Strong Sell with Increased Target to $17 on, Aug 8th, 2023

by: WOPRAI

Ryan Brinkman Maintained (APTV) at Hold with Increased Target to $123 on, Aug 8th, 2023

by: WOPRAI

Seamus Fernandez Initiated (APGE) at Strong Buy and Held Target at $29 on, Aug 8th, 2023

by: WOPRAI

Akash Tewari Initiated (APGE) at Strong Buy and Held Target at $29 on, Aug 8th, 2023

by: WOPRAI

Akash Tewari Initiated (APGE) at Strong Buy and Held Target at $34 on, Aug 8th, 2023

by: WOPRAI

David Nierengarten Initiated (APGE) at Buy and Held Target at $40 on, Aug 8th, 2023

by: WOPRAI

Tyler Van Buren Initiated (APGE) at Buy on, Aug 8th, 2023

by: WOPRAI

Ed Arce Reiterated (ARCT) at Strong Buy and Held Target at $51 on, Aug 8th, 2023

by: WOPRAI

Luca Issi Reiterated (ARWR) at Buy and Held Target at $60 on, Aug 8th, 2023

by: WOPRAI

Alethia Young Maintained (ARWR) at Buy with Decreased Target to $47 on, Aug 8th, 2023

by: WOPRAI

Keay Nakae Reiterated (ARWR) at Strong Buy and Held Target at $60 on, Aug 8th, 2023

by: WOPRAI

Amit Dayal Reiterated (ALTO) at Strong Buy and Held Target at $7 on, Aug 8th, 2023

by: WOPRAI

Keay Nakae Reiterated (ALNY) at Strong Buy and Held Target at $250 on, Aug 8th, 2023

by: WOPRAI

Scott Hanold Maintained (APA) at Hold with Increased Target to $50 on, Aug 8th, 2023

by: WOPRAI

Andrew Fein Reiterated (ANNX) at Strong Buy and Held Target at $30 on, Aug 8th, 2023

by: WOPRAI

Pete Stavropoulos Maintained (ANNX) at Buy with Decreased Target to $13 on, Aug 8th, 2023

by: WOPRAI

David Nierengarten Maintained (ANAB) at Hold with Decreased Target to $26 on, Aug 8th, 2023

by: WOPRAI

Andy Chen Initiated (AFMD) at Strong Buy and Held Target at $60 on, Aug 8th, 2023

by: WOPRAI

David Westenberg Maintained (ADPT) at Buy with Decreased Target to $14 on, Aug 8th, 2023

by: WOPRAI

Jason English Maintained (ADV) at Hold with Increased Target to $3.3 on, Aug 8th, 2023

by: WOPRAI

Raghuram Selvaraju Reiterated (ACRS) at Strong Buy and Held Target at $43 on, Aug 8th, 2023

by: WOPRAI

Chris Pierce Reiterated (ACVA) at Strong Buy and Held Target at $23 on, Aug 8th, 2023

by: WOPRAI

Daniel Imbro Reiterated (ACVA) at Buy and Held Target at $20 on, Aug 8th, 2023

by: WOPRAI

Nicholas Jones Maintained (ACVA) at Buy with Increased Target to $20 on, Aug 8th, 2023

by: WOPRAI

Gary Prestopino Reiterated (ACVA) at Buy and Held Target at $23 on, Aug 8th, 2023

by: WOPRAI

Rajat Gupta Maintained (ACVA) at Hold with Increased Target to $18 on, Aug 8th, 2023

by: WOPRAI

Nicholas Zangler Reiterated (ADEA) at Buy and Held Target at $17 on, Aug 8th, 2023

by: WOPRAI

Adam Jonas Maintained (ADNT) at Sell with Increased Target to $38 on, Aug 8th, 2023

by: WOPRAI

Joe Ahlersmeyer Maintained (BECN) at Strong Buy with Increased Target to $108 on, Aug 8th, 2023

by: WOPRAI

Michael Cyprys Maintained (BEN) at Sell with Increased Target to $24 on, Aug 8th, 2023

Jonathan Yong Maintained (CCRN) at Hold with Decreased Target to $26 on, Aug 8th, 2023

Jonathan Yong of Credit Suisse, Maintained "Cross Country Healthcare, Inc." (CCRN) at Hold with Decreased Target from $27 to $26 on, Aug 8th, 2023.

Jonathan has made no other calls on CCRN in the last 4 months.



There are 3 other peers that have a rating on CCRN. Out of the 3 peers that are also analyzing CCRN, 1 agrees with Jonathan's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Tobey Sommer of "Truist Securities" Maintained at Hold with Decreased Target to $25 on, Tuesday, May 2nd, 2023


These are the ratings of the 2 analyists that currently disagree with Jonathan

  • Trevor Romeo of "William Blair" Initiated at Buy on, Monday, June 26th, 2023
  • Kevin Steinke of "Barrington Research" Maintained at Buy with Decreased Target to $35 on, Thursday, June 1st, 2023

Like: 👍